Background and Purpose-A number of studies have examined the relationship between genetic platelet glycoprotein variants and early-onset atherothrombotic disease, particularly acute myocardial infarction. Data on the association of these genetic susceptibility markers with ischemic stroke are more limited, and their role in hemorrhagic stroke has not been previously examined. Methods-We performed genotype analysis for 5 common diallelic platelet glycoprotein polymorphisms in a populationbased study of 78 white women aged Ͻ45 years with arterial stroke (36 ischemic cases and 42 hemorrhagic cases) and 346 demographically similar control subjects. Results-The 807T variant of glycoprotein Ia was associated with a 2-fold increased risk of ischemic stroke (age-adjusted odds ratio [OR]ϭ2.24; 95% CIϭ0.99 to 5.06). The Met 145 allele of glycoprotein Ib␣ was associated with a trend toward an increased risk of ischemic stroke that was more pronounced in the homozygous state (ORϭ10.36), but the CI is extremely wide because of the small numbers of subjects (95% CIϭ1.43 to 79.34). Homozygosity for the Ser 843 allele of the glycoprotein IIb was associated with an Ϸ5-fold increased risk of ischemic stroke among subgroups of women who carried a diagnosis of hypertension or diabetes (ORϭ4.51; 95% CIϭ1.01 to 20.13) or had elevated plasma homocysteine levels (ORϭ5.94; 95% CIϭ1.53 to 23.05). The genotype distributions for all 5 platelet glycoprotein polymorphisms were similar among hemorrhagic stroke cases and controls. Conclusions-Several inherited platelet glycoprotein variants may be associated with an increased risk of ischemic stroke in young women. These associations seemed to be confined to women with other cardiovascular risk factors. Additional studies involving larger numbers of subjects are needed to confirm these preliminary findings. (Stroke.
P latelet thrombosis is mediated by several platelet membrane receptor complexes, including glycoprotein Ib/IX, glycoprotein Ia/IIa, and glycoprotein IIb/IIIa (Table 1) . Several genetic platelet glycoprotein variants have been associated with an increased risk of early-onset atherothrombotic disease, particularly acute myocardial infarction. 1 The potential contributions of these genetic platelet glycoprotein variants to the occurrence of ischemic stroke have been examined in a smaller number of studies. The Pro 33 variant of platelet glycoprotein IIIa and the Met 145 /VNTR-B allele of glycoprotein Ib␣ have been associated with ischemic stroke in some studies, but not in others. [2] [3] [4] [5] [6] [7] [8] Two other common platelet glycoprotein dimorphisms, glycoprotein IIb Ile/Ser 843 and glycoprotein Ia Glu/Lys 505 , were not associated with ischemic stroke in a single study, 7 but the Ile 843 variant of glycoprotein IIb was recently associated with increased mortality following ischemic stroke in an elderly patient population. 9 A nucleotide 807T variant of glycoprotein Ia that correlates with increased platelet surface levels of glycoprotein Ia/IIa (the platelet collagen receptor) 10 was recently associated with an increased risk of ischemic stroke with onset at a young age. 11 The inconsistent results of studies examining the risk of stroke associated with genetic platelet glycoprotein variants may be partly due to differences in demographic characteristics between study populations. For example, genetic prothrombotic factors may be more important in younger individuals or premenopausal women 12, 13 who are less likely to have advanced atherosclerotic disease. Furthermore, the effect of single genetic factors on the risk of stroke may be weak when analyzed individually but may be more pronounced in the presence of other common genetic or envi-ronmental cardiovascular risk factors (eg, hypertension, smoking, obesity). We therefore assessed the association of 5 common platelet glycoprotein polymorphisms with stroke in young women (aged Ͻ45 years) and examined potential interactions between these genetic variants and other traditional cardiovascular risk factors.
Subjects and Methods
This analysis is based on data and genetic material collected in a population-based case-control study of incident nonfatal stroke in young women. 14, 15 The study population consisted of women aged 18 to 44 years residing in 3 contiguous counties in western Washington State between July 1, 1991, and February 28, 1995. All subjects gave informed consent according to a protocol approved by the University of Washington and participating local hospitals. Stroke was defined as evidence of new focal neurological deficit(s) with no other apparent cause (ie, brain tumor, infection, subdural hematoma, seizure, or other neurological condition) lasting Ͼ24 hours. On the basis of review of hospital records, brain imaging studies, and lumbar puncture results, strokes were further classified by the study neurologist (W.T.L.) as ischemic, hemorrhagic, venous, or "other" (including arterial dissections). Random-digit telephone dialing was used to identify female control subjects, who were frequency matched to the age distribution of the cases.
One hundred forty-nine of 198 eligible patients with nonfatal stroke and 525 of 684 eligible control subjects were willing to participate in an in-person interview. The interview involved ascertainment of demographic characteristics and histories of traditional cardiovascular risk factors, including hypertension, diabetes, cigarette smoking, hypercholesterolemia, height, weight, contraceptive practices, menstrual status, and frequency of vigorous exercise. All interview questions elicited information about the time period before each subject's reference date, which was the date of stroke for cases and a date assigned at random from among the potential stroke occurrence dates for controls. A woman was classified as hypertensive, diabetic, or hypercholesterolemic if she reported ever receiving the diagnosis by a physician. Smokers were defined as subjects who reported smoking both currently (within a month of the reference date) and regularly (Ն5 cigarettes per week for Ն6 consecutive months). Obesity was defined as a body mass index Ն27.3 kg/m 2 .
Physical inactivity was defined as exercising vigorously Ͻ1 time per week. Hyperhomocysteinemia was defined as a serum homocysteine level Ͼ12.6 mol/L.
At the time of interview, venous blood samples were collected into EDTA-treated evacuated tubes from 106 participating stroke cases (54 hemorrhagic, 41 ischemic, 2 venous, and 9 "other") and from 391 participating control subjects. Plasma and genomic DNA samples were prepared as described previously. 14 , and glycoprotein Ia C807T) was performed by polymerase chain reaction amplification of genomic DNA followed by restriction enzyme digestion (polymerase chain reaction-restriction fragment length polymorphism), according to previously published methods. 16 -18 In a previous analysis of the overall study sample, we determined that there was a significantly greater proportion of black women among the hemorrhagic stroke cases (11.8%) and ischemic stroke cases (11.7%) than among the control subjects (2.5%). 14 Since the distribution of platelet glycoprotein alleles differs according to race, white and black subjects must be analyzed separately. However, because of the inadequate number of black women in the control group, we restricted the comparison of platelet glycoprotein genotypes to the subset of study subjects with DNA samples who were white (36 ischemic stroke cases, 42 hemorrhagic stroke cases, and 346 controls).
Platelet glycoprotein allele frequencies were calculated by gene counting. The association of platelet glycoprotein genotypes with stroke was examined by unconditional logistic regression adjusted for age and was expressed as odds ratios (ORs) and 95% CIs. Unless otherwise noted, ORs for the 5 biallelic platelet glycoprotein polymorphisms were calculated comparing individuals who were either heterozygous or homozygous for the less common allele with individuals who were homozygous for the more common allele. We also assessed the extent to which associations with platelet glycoprotein polymorphisms were modified by other cardiovascular risk factors, including smoking, obesity, hypertension, diabetes, and hyperhomocysteinemia, through analyses stratified on these cardiovascular risk factors.
Results
A comparison of the characteristics of stroke cases and control subjects among the subset of white women with DNA samples is presented in Table 2 . The frequencies of various cardiovascular risk factors among ischemic stroke cases, hemorrhagic stroke cases, and control subjects were similar to those previously reported in an analysis based on a larger sample size from this study population. 14 Current cigarette smoking, hypertension, and physical inactivity were more common in both ischemic stroke cases and hemorrhagic stroke cases than control subjects. Higher plasma levels of total homocysteine were also noted in both the ischemic and hemorrhagic stroke patients compared with control subjects. In contrast, higher frequencies of obesity and diabetes were confined to the ischemic stroke cases.
The genotype distributions of the 5 platelet glycoprotein polymorphisms among the ischemic stroke cases and control subjects are compared in Table 3 . A trend toward an association with risk of ischemic stroke was observed for the glycoprotein Ia C807T, glycoprotein Ib␣ Thr/Met 145 , and glycoprotein IIb Ile/Ser 843 polymorphisms, but none of these reached the level of statistical significance in the overall study sample. The age-adjusted OR for women carrying Ն1 copy of the 807T allele was 2.24, and the lower confidence limit was just Ͻ1.0 (95% CIϭ0.99 to 5.06). When analyzed by subgroups defined according to the presence or absence of other cardiovascular risk factors, the risk of ischemic stroke contrast, the risk associated with homozygosity for the glycoprotein IIb Ser 843 allele was not increased in women without hypertension or diabetes (ORϭ0.94; 95% CIϭ0.27 to 3.33) or in women with normal plasma homocysteine levels (ORϭ0.83; 95% CIϭ0.23 to 2.94).
The genotype distributions of the 5 platelet glycoprotein polymorphisms in hemorrhagic stroke cases and control subjects are compared in Table 4 . The genotype distributions were similar between hemorrhagic stroke cases and controls, either overall or in the presence or absence of other cardiovascular risk factors (data not shown).
Discussion
Our results suggest possible associations between 3 platelet glycoprotein polymorphisms, glycoprotein Ia C807T, glycoprotein IIb Ile/Ser 843 , and glycoprotein Ib␣ Thr/Met
145
, and risk of ischemic stroke in young women. Although the observed associations were modest, and the study was limited by small numbers of stroke cases, 2 features of the study suggest that these preliminary results may represent authentic associations. First, there was evidence that the risk of ischemic stroke associated with these genetic platelet glycoprotein variants was highest in subgroups of women with other known cardiovascular risk factors. These results are consistent with previous studies that indicate the importance of genetic prothrombotic factors in combination with other cardiovascular risk factors in the occurrence of atherothrombotic diseases such as myocardial infarction in young adults. 19 -21 Second, we did not observe an association between any of the platelet glycoprotein polymorphisms and risk of hemorrhagic stroke, a disorder that does not involve platelet-dependent thromboembolism.
Glycoprotein Ia/IIa is the major platelet collagen receptor and is responsible for platelet adherence to exposed vascular subendothelium. The 807T allele of glycoprotein Ia was recently associated with a statistically significant 3-fold increased risk of stroke in men and women aged Ͻ50 years but was not associated with stroke in patients aged Ͼ50 years. 11 Our results in young women indicate an Ϸ2-fold increased risk of ischemic stroke associated with the 807T variant that was highest in women who were either obese or had elevated plasma homocysteine levels. An increased risk of myocardial infarction associated with the glycoprotein Ia 807T allele similarly has been reported in young obese men. 22 The platelet glycoprotein Ib/IX complex is the major platelet receptor for von Willebrand factor and is responsible for initial platelet adhesion and activation following exposure to vascular subendothelium under high shear rates. GonzalezConejero et al 4 tein IIIa and risk of atherothrombotic stroke only in the subgroup of patients aged Ͻ50 years. Wagner et al 3 reported a trend toward an association between the Pro 33 variant of platelet glycoprotein IIIa and cerebral infarction in women aged Ͻ45 years when the analysis was restricted to whites. In contrast, we found no association between the glycoprotein IIIa Pro 33 variant and risk of ischemic stroke in our population of young white women. Our negative findings are consistent with the results of 2 other case-control studies, 6, 7 as well as a prospective study of male physicians. 8 The 23 and thus provides a possible explanation for the association between the Ser 843 variant and risk of atherothrombotic disease.
Our findings are in contrast with another recent study that noted an association between the more common Ile 843 variant of glycoprotein IIb and increased risk of poststroke mortality in an older patient population. 9 Since our study analyzed only women who survived their acute event, it is possible that the women who died acutely had an overrepresentation of the Ile 843 variant. Given the possible increased in vitro thrombogenicity of the Ser 843 variant, 23 one may speculate that the less adhesive Ile 843 allele is associated with a increased tendency toward embolization of a preexisting platelet thrombus; this might account for increased mortality following the acute atherothrombotic event. 9 Several limitations of our study should be noted. First, the relatively small number of cases and the performance of multiple subgroup analyses may increase the likelihood of a spurious association (type I statistical error). In this regard, some polymorphisms that have been associated with stroke or myocardial infarction in smaller studies have not been verified in larger, prospective studies. 1, 8 Second, the small number of cases decreases the likelihood of detecting weak associations (type II error). Third, blood samples for DNA analysis were collected at the time of subject interview; thus, as noted above, our study includes only women who survived an acute stroke. Therefore, if a particular platelet glycoprotein allele was associated with increased morbidity or early mortality, the effect could be underestimated because of exclusion of women who died acutely or were severely disabled. Fourth, our results apply to white, premenopausal women with acute stroke and may not be generalized to other demographic and ethnic groups.
Thus, confirmation of the role of genetic platelet glycoprotein variants as risk factors for early-onset ischemic stroke requires further study involving larger numbers of subjects and other populations.
